Logo

Bone Health's OsteoBoost Vibration Belt Receives the US FDA's Breakthrough Device Designation for Osteoporosis

Share this

Bone Health's OsteoBoost Vibration Belt Receives the US FDA's Breakthrough Device Designation for Osteoporosis

Shots:

  • OsteoBoost receives the US FDA’s BDD to reduce the risk of osteoporosis. It uses vibration technology that delivers mechanical stimulation to the hips & spine at a precise- individually calibrated frequency- encouraging the body to reduce bone resorption & potentially create new bone
  • An initial study showed that just one 30min treatment with OsteoBoost reduced bone loss activity in all participants- showing a decrease of 14%- a reduction on par with bisphosphonate drugs
  • The NIH funded a $2M to study for determining the positive effects of OsteoBoost in a larger study with a broader population. The larger study is currently enrolling patients & is scheduled to be completed in early 2022

 ­ Ref: Bone Health Tech | Image: Linkedin

Click here to­ read the full press release 

Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions